Mike Coyle is the CEO of iRhythm, and Mark Day is the Executive Vice President of Research & Development of iRhythm, a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities. Together, they speak with us about how AI can help diagnose heart problems and enable longer-term cardiac monitoring. They discuss iRhythm's technology, its business strategy, and the power of AI-human collaboration.

Pranav and Adriel first give an overview on heart arrhythmias and ambulatory ECGs. The interview with Mike and Mark starts at 6:42. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.